CHB
Global X China Biotech Innovation ETF
Delisted
CHB was delisted on the 16th of February, 2024.
0 hedge funds and large institutions have $0 invested in Global X China Biotech Innovation ETF in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$197K |
| 2 |
Jane Street
New York
|
-$176K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$186 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| – | -$197K | -24,314 | Closed |
|
|
2
Jane Street
New York
| – | -$176K | -21,688 | Closed |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$186 | -23 | Closed |
|